BioArctic AB (publ) (STO:BIOA.B)

BioArctic AB Cash Flow Statement

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	901.96	-177.08	229.25	-11.18	-119.79	-68.52
Depreciation & Amortization	11.76	10.72	7.44	14.08	13.05	11.01
Loss (Gain) From Sale of Assets	-	-	-	-	-	0.21
Stock-Based Compensation	19.33	19.33	16.14	2.76	1.57	1.32
Other Operating Activities	-9.86	-106.74	43.72	-62.21	-30.22	-62.92
Change in Accounts Receivable	-1,051	-105.23	-11.98	-2.41	-5.12	23.09
Change in Other Net Operating Assets	-62.15	42.66	25.13	27.33	0.06	3.47
Operating Cash Flow	-190.14	-316.33	309.69	-31.64	-140.46	-92.34
Capital Expenditures	-26.64	-26.64	-7.44	-12.75	-4.39	-12.47
Investment in Securities	232.27	232.27	-500.04	-0.02	-0.03	-0.05
Other Investing Activities	48.7	0	-	0	0	-
Investing Cash Flow	254.34	205.63	-507.49	-12.76	-4.41	-12.52
Long-Term Debt Repaid	-	-0.33	-0.92	-8.79	-7.39	-6.6
Net Debt Issued (Repaid)	-0.33	-0.33	-0.92	-8.79	-7.39	-6.6
Issuance of Common Stock	6.02	6.02	14.98	5.99	-	-
Other Financing Activities	10.33	-0	-0	-	-	-
Financing Cash Flow	16.02	5.69	14.06	-2.81	-7.39	-6.6
Foreign Exchange Rate Adjustments	-12.68	6.37	-10.09	4.19	0.72	-1.37
Miscellaneous Cash Flow Adjustments	0	-	-	-0	-	-
Net Cash Flow	67.54	-98.64	-193.82	-43.02	-151.54	-112.83
Free Cash Flow	-216.77	-342.97	302.25	-44.38	-144.84	-104.81
Free Cash Flow Margin	-14.29%	-133.27%	49.07%	-19.35%	-564.40%	-160.74%
Free Cash Flow Per Share	-2.45	-3.87	3.42	-0.50	-1.65	-1.19
Cash Interest Paid	1.85	1.85	0.38	0.75	0.98	1.69
Cash Income Tax Paid	42.33	0.52	-0.16	-0.34	0.31	12.22
Levered Free Cash Flow	-54.76	-290.3	210.92	-34.44	-91.07	-70.21
Unlevered Free Cash Flow	-45.93	-290.3	211.13	-34.09	-90.55	-69.59
Change in Working Capital	-1,113	-62.57	13.15	24.91	-5.06	26.56

Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.